SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-057662
Filing Date
2021-04-29
Accepted
2021-04-29 16:30:31
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2114338d1_defa14a.htm DEFA14A 119118
2 GRAPHIC tm2114338d1_defa14aimg004.jpg GRAPHIC 2805
3 GRAPHIC tm2114338d1_defa14aimg005.jpg GRAPHIC 21588
4 GRAPHIC tm2114338d1_defa14aimg001.jpg GRAPHIC 7902
5 GRAPHIC tm2114338d1_defa14aimg002.jpg GRAPHIC 13410
6 GRAPHIC tm2114338d1_defa14aimg003.jpg GRAPHIC 5984
7 GRAPHIC image_004.jpg GRAPHIC 5984
  Complete submission text file 0001104659-21-057662.txt   200540
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 21871164
SIC: 2834 Pharmaceutical Preparations